| Endocrine and metabolic changes in women with polycystic ovaries and with polycystic ovary syndrome | ||
|---|---|---|
| Prev | ||
Aakvaag A and H Gjönnaess (1985) Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease. Br J Obstet Gynaecol 92(12): 1258-1264.
Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD & Reaven GM (1997) Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue. Diab Care 20(12): 1863-1869.
Abbasi F, Carantoni M, Chen YD & Reaven GM (1998). Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diab Care 21(8): 1301-1305.
Abdel Gadir, A, Khatim MS, Mowafi RS, Alnaser HM, Muharib NS & Shaw RW (1992) Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 7(4): 453-457.
Acbay O & Gundogdu S (1996) Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 65(5): 946-949.
Achard C & Thiers J (1921). Le virilisme pilaire et son association a l"insuffisance glycolytique (diabetes des femmes á barbe). Bull Acad Natl Med (Paris) 86: 51-64.
Adams J, Franks S, Polson DW & Mason HD (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2(8469-70): 1375-1379.
Adams J, Polson DW & Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J Clin Res Ed. 293(6543): 355-359.
Adashi EY, Rock JA, Guzick D, Wentz AC, Jones GS & Jones HW. (1981) Fertility following bilateral ovarian wedge resection: a critical analysis of 90 consecutive cases of the polycystic ovary syndrome. Fertil Steril 36(3): 320-325.
Adashi EY, Resnick CE, D"Ercole AJ, Svoboda ME & Van Wyk JJ (1985) Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6(3): 400-420.
Adashi, E. Y. (1990) Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism. Fertil Steril 53(5): 765-779.
Agarwal SK, Vogel K, Weitsman SR & Magoffin DA (1999) Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 84(3): 1072-1076.
Almahbobi G, Anderiesz C, Hutchinson P, McFarlane JR, Wood C & Trounson AO (1996) Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol 44(5): 571-580.
Amsterdam A, Knecht M & Catt KJ (1981) Hormonal regulation of cytodifferentiation and intercellular communication in cultured granulosa cells. Proc Nat Acad Sc U S A 78(5): 3000-3004.
Anonymous (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diab Care 20(7): 1183-1197.
Anttila L, Karjala K, Penttila RA, Ruutiainen K & Ekblad U (1998). Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 92(1): 13-16.
Apter D, Butzow T, Laughlin GA & Yen SS (1994a) Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab 79(1): 119-125.
Apter D, Bützow T, Laughlin GA & Yen SSC (1994b) Increasing the clinical value of serum LH measurements by reducing short term variation. Presented in 20th Spring Meeting of the Finnish Endocrine Society. Tallinn, Estonia.
Apter D, Butzow T, Laughlin GA & Yen SS (1995) Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 80(10): 2966-2973.
Arner P (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Annals of Medicine 27(4): 435-438.
Arroyo A, Laughlin GA, Morales AJ & Yen SS (1997) Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82(11): 3728-3733.
Atiomo WU, Pearson S, Shaw S, Prentice A & Dubbins P (2000) Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS). Ultrasound Med Biol 26(6): 977-980.
Azziz R & Kashar-Miller MD (2000) Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab 13(Suppl 5): 1303-1306
Azziz R, Ehrmann D, Whitcomb RW, Hanley R, Fereshetian AG, O"Keefe M & Ghazzi MN (2001) Troglitazone improves ovulation and hirsutism in the polycystic ovarian syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86 (4):1626-1631.
Bailey CJ, Flatt PR & Ewan C (1986) Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice. Archives Internationales de Pharmacodynamie et de Therapie 282(2): 233-239.
Balen AH (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod 8(Suppl 2): 123-128.
Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Kaplinski A, Roguski K & Plonowski A (1999) Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol 13(5): 344-351.
Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW & Ryan KJ (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62(5): 904-910.
Barnes R & Rosenfield RL (1989a) The polycystic ovary syndrome: pathogenesis and treatment. Ann Int Med 110(5): 386-399.
Barnes RB, Rosenfield RL, Burstein S & Ehrmann DA (1989b). “Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.” N Engl J Med 320(9): 559-565.
Bates GW & Whitworth NS (1982) Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 38(4): 406-409.
Beer NA, Jakubowicz DJ, Beer RM & Nestler JE (1994) Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinol Metab 79(4): 1077-1081.
Bergman RN, Prager R, Volund A & Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79(3): 790-800.
Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38(12): 1512-1527.
Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA & Ferrannini E (1987) Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metab: Clin Exp 36(5): 502-506.
Bjorntorp P (1996) The regulation of adipose tissue distribution in humans. International Journal of Obesity & Related Metabolic Disorders 20(4): 291-302.
Bleau G, Roberts KD & Chapdelaine A (1974) The in vitro and in vivo uptake and metabolism of steroids in human adipose tissue. J Clin Endocrinol Metab 39(2): 236-246.
Boden G, Chen X, Kolaczynski JW & Polansky M (1997) Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100(5): 1107-1113.
Borgfeldt C & and Andolf E (1999) Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultras Obstet Gynecol 13(5): 345-350.
Botsis D, Kassanos D, Pyrgiotis E & Zourlas PA (1995) Sonographic incidence of polycystic ovaries in a gynecological population. Ultras Obstet Gynecol 6(3): 182-185.
Bray GA & York DA (1997) Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 82(9): 2771-2776.
Breteche J (1952) Kystes ovariques et ovarites sclero-cystique dans la sterilite. Bull Fed Gynecol Obstet Fr 4: 149-155.
Bringer J, Lefebvre P, Boulet F, Grigorescu F, Renard E, Hedon B, Orsetti A & Jaffiol C (1993) Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann N Y Acad Sci 687: 115-123.
Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP & Magoffin DA (1996) Serum Immunoreactive Leptin Concentrations in Women with polycystic Ovary Syndrome. J Clin Endocrinol Metab 81(11): 4166-4169.
Buchanan TA, Metzger BE, Freinkel N & Bergman RN (1990) Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162(4): 1008-1014.
Burghen GA, Givens JR & Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.” J Clin Endocrinol Metab 50(1): 113-116.
Buschard K, Buch I, Molsted-Pedersen L, Hougaard P & Kuhl C (1987) Increased incidence of true type I diabetes acquired during pregnancy. Br Med J Clin Res Ed. 294(6567): 275-279.
Buttram V C Jr & Vaquero C (1975) Post-ovarian wedge resection adhesive disease. Fertil Steril 26(9): 874-876.
Bützow TL, Kettel LM & Yen SS (1995) Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome. Fertil Steril 63(6):1200-1203.
Bützow T, Moilanen JM, Lehtovirta M, Tuomi T, Hovatta O, Siegberg R, Nilsson C & Apter D (1999) Serum and follicular fluid leptin during in vitro fertilization:Relationship among leptin increase, body fat mass, and reduced ovarian response. J Clin Endocrinol Metab 84(9): 3135-3139.
Bützow T, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppälä M & Apter D (2000) The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women. J Clin Endocrinol Metab 85(9): 3271-3275.
Byrne MM, Sturis J, O"Meara NM & Polonsky KS (1995) Insulin secretion in insulin-resistant women with a history of gestational diabetes. Metab: Clin Exp 44(8): 1067-1073.
Cagnacci A, Soldani R, Paoletti AM, Falqui A & Melis GB (1994) Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome. Fertil Steril 62(2): 269-272.
Cameron OG, Kronfol Z, Greden JF & Carroll BJ (1984) Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gener Psych 41(11): 1090-1095.
Campbell PJ & Gerich JE (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 70(4): 1114-1118.
Carey AH, Chan KL, Short F, White D, Williamson R & Franks S (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38(6): 653-658.
Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ & Lobo RA (1997) Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 12(5): 905-909.
Carmina E & Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6): 1897-1899.
Cataldo NA & Giudice LC (1992) Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 74(4): 821-829.
Cataldo NA (1997) Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome? Semin Reprod Endocrinol 15(2): 123-136.
Chamlian DL & Taylor HB (1970) Endometrial hyperplasia in young women. Obstet Gynecol 36(5): 659-666.
Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV & Lobo RA (2000) Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 85(3): 995-1000.
Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu JK, Vale WW, Rivier JE & Judd HL (1983) Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 56(5): 897-903.
Cheatham B & Kahn CR (1995) Insulin action and the insulin signaling network. Endocr Rev 16(2): 117-142.
Chehab FF, Lim ME & Lu R (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Gen 12: 318-320.
Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Caruso A, Mancuso S & Lanzone A (1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12(9): 1897-1901.
Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM & Yen SS (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75(2): 577-583.
Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J & Skibova J (2000) Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15(4): 785-789.
Cioffi JA, Van Blerkom J, Antczak M, Shafer A, Wittmer S & Snodgrass HR (1997) The expression of leptin and its receptors in pre-ovulatory human follicles. Mol Hum Reprod 3(6): 467-472.
Clarke IJ, Cummins JT, Findlay JK, Burman KJ & Doughton BW (1984) Effects on plasma luteinizing hormone and follicle-stimulating hormone of varying the frequency and amplitude of gonadotropin-releasing hormone pulses in ovariectomized ewes with hypothalamo-pituitary disconnection. Neuroendocrinol 39(3): 214-321.
Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S & Meade TW (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?. Clin Endocrinol 37(2): 127-134.
Cohen B, Novick D & Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274(5290): 1185-1188.
Conn JJ, Jacobs HS & Conway GS (2000) The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 52(1): 81-86.
Conway GS, Honour JW & Jacobs HS (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 30(4): 459-470.
Conway GS, Agrawal R, Betteridge DJ & Jacobs HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 37(2): 119-125.
Cooper, H. E., W. N. Spellacy et al. (1968). “Hereditary factors in the Stein-Leventhal syndrome.” American Journal of Obstetrics & Gynecology 100: 371-380.
Coulam CB, Annegers JF & Kranz JS (1983) Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 61(4): 403-407.
Couzinet B, Lestrat N, Brailly S, Forest M & Schaison G (1988) Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 66(3): 552-556.
Cramer DW, Petterson KS, Barbieri RL & Huhtaniemi IT (2000) Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum Reprod 15(10): 2103-2107.
Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H & Pugeat M (1995) Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80(7): 2057-2062.
Crook D, Godsland IF, Hull J & Stevenson JC (1997) Hormone replacement therapy with dydrogesterone and 17 beta-estradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br J Obstet Gynaecol 104(3): 298-304.
Crosby PD & Rittmaster RS (1991) Predictors of clinical response in hirsute women treated with spironolactone. Fertil Steril 55(6): 1076-1081.
Dabirashrafi H (1989) Complications of laparoscopic ovarian cauterization. Fertil Steril 52(5): 878-879.
Dabirashrafi H, Mohamad K, Behjatnia Y & Moghadami-Tabrizi N (1991) Adhesion formation after ovarian electrocauterization on patients with polycystic ovarian syndrome. Fertil Steril 55(6): 1200-1201.
Dahlgren E, Friberg LG, Johansson S, Lindstrom B, Oden A, Samsioe G & Janson PO (1991) Endometrial carcinoma. Ovarian Dysfunction- a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 41: 143-150.
Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N & Lundberg PA (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57(3): 505-513.
Dahlgren E & Janson PO (1994a) Polycystic ovary syndrome--long-term metabolic consequences. Int J Gynaecol Obstet 44(1): 3-8.
Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G & Tengborn L (1994b) Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 61(3): 455-460.
Daly DC, Walters CA, Soto-Albors CE, Tohan N & Riddick DH (1984) A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 41(6): 844-848.
Damm P, Kuhl C, Bertelsen A & Molsted-Pedersen L (1992) Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 167(3): 607-616.
Damm P, Kuhl C, Hornnes P & Molsted-Pedersen L (1995) A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diab Care 18(5): 654-665.
de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G & Alberti KG. (1997) Hyperleptinaemia: the missing link in the, metabolic syndrome? Diab Med 14(3): 200-208.
De Leo V, la Marca A, Ditto A, Morgante G & Cianci A (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72(2): 282-285.
De Leo V, la Marca A, Morgante G, Ciotta L, Mencaglia L, Cianci A & Petraglia F (2000) Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome. Hum Reprod 15(11): 2302-2305.
DeFronzo RA, Tobin JD & Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3): E214-223.
DeFronzo RA & Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333(9): 541-549.
D"Ercole AJ, Underwood LE, Groelke J & Plet A (1979) Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab 48(3): 495-502.
Dewailly D (1997) Definition and significance of polycystic ovaries. Baill Clin Obstet Gynaecol 11(2): 349-368.
Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, Tsianateli TC & Kouli CR (2000) Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 73(4): 735-741.
Dornhorst A, Bailey PC, Anyaoku V, Elkeles RS, Johnston DG & Beard RW (1990) Abnormalities of glucose tolerance following gestational diabetes. Quart J Med 77(284): 1219-1228.
Drop SL (1991) Report on the nomenclature of te IGF binding proteins. Acta Endocrinol 125(6): 707-708.
Dunaif A, Graf M, Mandeli J, Laumas V & Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65(3): 499-507.
Dunaif A & Graf M (1989a) Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 83(1): 23-29.
Dunaif A, Segal KR, Futterweit W & Dobrjansky A (1989b) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38(9): 1165-1174.
Dunaif A, Green G, Futterweit W & Dobrjansky A (1990) Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 70(3): 699-704.
Dunaif A (1995a) Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 98(1A): 33S-39S.
Dunaif A, Xia J, Book CB, Schenker E & Tang Z (1995b) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96(2): 801-810.
Dunaif A & Finegood DT (1996a) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81(3): 942-947.
Dunaif A, Scott D, Finegood D, Quintana B & Whitcomb R (1996b) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81(9): 3299-3306.
Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18(6): 774-800.
Dunaif A (1999) Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin N A 28(2): 341-359.
Eden JA, Jones J, Carter GD & Alaghband-Zadeh J (1990) Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles. Clin Endocrinol 32(4): 395-405.
Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA & Vinson GP (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19(2): 101-143.
Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF & Sheikh Z (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327(3): 157-162.
Ehrmann DA, Barnes RB & Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16(3): 322-353.
Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL & Polonsky KS (1997a) Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82(2): 524-530.
Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL & Polonsky KS (1997b) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82(7): 2108-2116.
Eil C & Edelson SK (1984) The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metab 59(1): 51-55.
Ek I, Arner P, Bergqvist A, Carlstrom K & Wahrenberg H (1997) Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? J Clin Endocrinol Metab 82(4): 1147-1153.
el Tabbakh GH, Lotfy I, Azab I, Rahman HA, Southren AL & Aleem FA (1986) Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings. Am J Obstet Gynecol 154(4): 892-895.
Elkind-Hirsch KE, Valdes CT & Malinak LR (1993) Insulin resistance improves in hyperandrogenic women treated with Lupron. Fertil Steril 60(4): 634-641.
el-Roeiy A, Chen X, Roberts VJ, Shimasakai S, Ling N, LeRoith D, Roberts CT Jr & Yen SS (1994) Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78(6): 1488-1496.
Elting MW, Korsen TJ, Rekers-Mombarg LT & Schoemaker J (2000) Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 15(1): 24-28.
Erenus M, Gurbuz O, Durmusoglu F, Demircay Z & Pekin S (1994) Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril 61(4): 613-616.
Erenus M, Yucelten D, Durmusoglu F & Gurbuz O (1997) Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril 68(6): 1000-1003.
Erickson GF & Ryan KJ (1976) Stimulation of testosterone production in isolated rabbit thecal tissue by LH/FSH, dibutyryl cyclic AMP, PGE2alpha, and PGE2. Endocrinol 99(2): 452-458.
Erickson GF, Hsueh AJ, Quigley ME, Rebar RW & Yen SS (1979) Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 49(4): 514-519.
Erickson GF, Garzo VG & Magoffin DA (1989) Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab 69(4): 716-724.
Erickson GF, Magoffin DA, Cragun JR & Chang RJ (1990) The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 70(4): 894-902.
Erickson GF, Chung DG, Sit A, DePaolo LV, Shimasaki S & Ling N (1995) Follistatin concentrations in follicular fluid of normal and polycystic ovaries. Hum Reprod 10: 2120-2124.
Erickson JC, Hollopeter G & Palmiter RD (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274(5293): 1704-1707.
Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C & Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321(6): 337-343.
Escobar O, Mizuma H, Sothern MS, Blecker U, Udall JN Jr, Suskind RM, Hilton C, Vargas A (1999) Hepatic insulin clearance increases after weight loss in obese children and adolescents. Am J Med Sc 317(5): 282-286.
Escobar-Morreale HF, Roldan B, Barrio R, Alonso M, Sancho J, de la Calle H & Garcia-Robles R (2000) High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 85(11): 4182-4187.
Evans DJ, Hoffmann RG, Kalkhoff RK & Kissebah AH (1983) Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57(2): 304-310.
Faddy MJ, Gosden RG, Gougeon A, Richardson SJ & Nelson JF (1992) Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7(10): 1342-1346.
Falsetti L, De Fusco D, Eleftheriou G & Rosina B (1997) Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome. Gynecol Endocrinol 11(4): 251-257.
Farquhar CM, Birdsall M, Manning P, Mitchell JM & France JT (1994) The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Austr N Z J Obstet Gynaecol 34(1): 67-72.
Farrell J, Forrest JM, Storey GN, Yue DK, Shearman RP & Turtle JR (1986) Gestational diabetes--infant malformations and subsequent maternal glucose tolerance. Austr N Zeal J Obstet Gynaecol 26(1): 11-16.
Fauser BC & De Jong FH (1993) Gonadotropins in polycystic ovarian syndrome. Ann N Y Acad Sc 687: 150-161.
Fedele D, Tiengo A, Nosadini R, Marchiori E, Briani G, Garotti MC & Muggeo M (1976) Hypolipidemic effects of metformin in hyperprebetalipoproteinemia. Diabete et Metabolisme 2(3): 127-133.
Feldman D (1986) Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev 7(4): 409-420.
Felemban A, Tan SL & Tulandi T (2000) Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 73(2): 266-269.
Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metab: Clin Exp 37(3): 287-301.
Ferriman D & Gallwey J (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21: 1440-1447.
Ferriman D & Purdie AW (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol 11(3): 291-300.
Folsom AR, Kaye SA, Potter JD & Prineas RJ (1989) Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women"s Health Study. Canc Res 49(23): 6828-6831.
Forest MG, Lecoq A & Saez JM (1979) Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 alpha-hydroxyprogesterone, delta4-androstenedione, estrone, and 17 beta-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J Clin Endocrinol Metab 49(2): 284-291.
Franks S, Adams J, Mason H & Polson D (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 12(3): 605-632.
Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R & McCarthy M (1997) The genetic basis of polycystic ovary syndrome. Hum Reprod 12(12): 2641-2648.
Fulghesu AM, Lanzone A, Guida C, Nicoletti MC, Rossi P, Le Donne M, Caruso A & Mancuso S (1992) Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study. J Reprod Med 37(10): 834-840.
Fulghesu AM, Lanzone A, Cucinelli F, Caruso A & Mancuso S (1993) Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease. Obstet Gynecol 82(2): 191-197.
Fulghesu AM, Ciampelli M, Guido M, Murgia F, Caruso A, Mancuso S & Lanzone A (1998) Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. Metab: Clin Exp 47(2): 158-162.
Furui K, Suganuma N, Tsukahara S, Asada Y, Kikkawa F, Tanaka M, Ozawa T & Tomoda Y (1994) Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J Clin Endocrinol Metab 78(1): 107-113.
Futterweit W & Mechanick JI (1988) Polycystic ovarian disease: etiology, diagnosis, and treatment. Compreh Ther 14(11): 12-20.
Gilling-Smith C, Willis DS, Beard RW & Franks S (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79(4): 1158-1165.
Gilling-Smith C, Story H, Rogers V & Franks S (1997a) Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol 47(1): 93-99.
Gilling-Smith C, Willis DS & Franks S (1997b) Oestradiol feedback stimulation of androgen biosynthesis by human theca cells. Hum Reprod 12(8): 1621-1628.
Giudice LC (1992) Insulin-like growth factors and ovarian follicular development. Endocr Rev 13(4): 641-669.
Giudice LC (1999) Growth factor action on ovarian function in polycystic ovary syndrome. Endocrinol Metab Clin N A 28(2): 325-339.
Giugliano D, Salvatore T, Cozzolino D, Ceriello A, Torella R & D"Onofrio F (1987) Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus. J Clin Endocrinol Metab 64(6): 1122-1128.
Givens JR, Andersen RN, Wiser WL & Fish SA (1974) Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab 38(5): 727-735.
Gjönnaess H (1984) Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 41(1): 20-25.
Gjönnaess H (1989) The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight. Br J Obstet Gynaecol 96(6): 714-719.
Godsland IF, Walton C, Felton C, Proudler A, Patel A & Wynn V (1992) Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 74(1): 64-70.
Gokmen O, Senoz S, Gulekli B & Isik AZ (1996) Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome. Gynecol Endocrinol 10(4): 249-255.
Goldzieher J & Green J (1962). The polycystic ovary: I. Clinical and histologic features. J Clin Endocrinol Metab 22: 325-338.
Goldzieher J & Green J (1963) Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14: 631-653.
Gonzalez F, Chang L, Horab T & Lobo RA (1996) Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome. Fertil Steril 66(3): 354-361.
Goode GK, Miller JP & Heagerty AM (1995) Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 345(8946): 362-364.
Govind A, Obhrai MS & Clayton RN (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84(1): 38-43.
Grigoriou O, Papadias C, Konidaris S, Antoniou G, Karakitsos P & Giannikos L (1996) Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial. Gynecol Endocrinol 10(2): 119-123.
Guzick D (1998) Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol 179(6 Pt 2): S89-S93.
Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH & Wolfson SK Jr (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 174(4): 1224-1229
Gülekli B, Turhan NÖ, Senöz S, Kükner S, Gökmen O (1993) Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study. Gynecol Endocrinol 7: 273-277.
Haavisto AM, Pettersson K, Bergendahl M, Virkamaki A & Huhtaniemi I (1995) Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 80(4): 1257-1263.
Haavisto AM (1996) Bioactive and immunoreactive luteinizing hormone in serum: Methodological improvements and clinical significance. Acta Univ Turkuens D 220: 38-39.
Hadden DR (1985) Geographic, ethnic, and racial variations in the incidence of gestational diabetes mellitus. Diabetes 34(Suppl 2): 8-12.
HagueWM, Adams J, Reeders ST, Peto TE & Jacobs HS (1988) Familial polycystic ovaries: a genetic disease? Clin Endocrinol 29(6): 593-605.
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK & Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223): 543-546.
Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppala M & Franks S (1993) Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin Endocrinol 39(3): 363-367.
Hammond CB, Jelovsek FR, Lee KL, Creasman WT & Parker RT (1979) Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 133(5): 537-547.
Haning RV, Hackett RJ, Flood CA, Loughlin JS, Zhao QY & Longcope C (1993) Testosterone, a follicular regulator: key to anovulation. J Clin Endocrinol Metab 77(3): 710-715.
Harlass FE, Plymate SR, Fariss BL & Belts RP (1984) Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 42(4): 649-652.
Harlin J, Khan SA & Diczfalusy E (1986) Molecular composition of luteinizing hormone and follicle-stimulating hormone in commercial gonadotropin preparations. Fertil Steril 46(6): 1055-1061.
Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T & Tanaka K (1999) Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 71(2): 323-327.
Hillier SG, Wickings EJ, Illingworth PI, Yong EL, Reichert LE, Baird DT & McNeilly AS (1991) Control of immunoactive inhibin production by human granulosa cells. Clin Endocrinol 35(1): 71-78.
Hillier SG & Miro F (1993) Inhibin, activin, and follistatin. Potential roles in ovarian physiology. Ann NY Acad Sci 687: 29–38.
Hillier SG & Tetsuka M (1997) Role of androgens in follicle maturation and atresia. Baill Clin Obstet Gynaecol 11(2): 249-260.
Hillier, S.G. (1999) Intragonadal regulation of male and female reproduction. Ann Endocrinol 60: 111–117.
Hoffman DI, Klove K & Lobo RA (1984) The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 42(1): 76-81.
Holle A, Mangels W, Dreyer M, Kuhnau J & Rudiger HW (1981) Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. N Engl J Med 305(10): 563-566.
Holly JM, Eden JA, Alaghband-Zadeh J, Carter GD, Jemmott RC, Cianfarani S, Chard T & Wass JA (1990) Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries. Clin Endocrinol 33(1): 53-64.
Holmang A, Larsson BM, Brzezinska Z & Bjorntorp P (1992) Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats. Am J Physiol 262(6 Pt 1): E851-855.
Holte J, Bergh T, Gennarelli G & Wide L (1994) The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 41(4): 473-481.
Holte J, Bergh T, Berne C, Wide L & Lithell H (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80(9): 2586-2593.
Holte J (1996) Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baill Clin Endocrinol Metab 10(2): 221-247.
Holte J, Gennarelli G, Wide L, Lithell H & Berne C (1998) High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 83(4): 1143-1150.
Homburg R, Armar NA, Eshel A, Adams J & Jacobs HS (1988) Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 297(6655): 1024-1026.
Homburg R, Eshel A, Kilborn J, Adams J & Jacobs HS (1990) Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod 5(1): 32-35.
Homburg R, Pariente C, Lunenfeld B & Jacobs HS (1992) The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod 7(10): 1379-1383.
Hsueh AJ, Dufau ML & Catt KJ (1976) Regulation of luteinizing hormone receptors in testicular interstitial cells by gonadotropin.” Biochem Biophys Res Comm 72(3): 1145-1152.
Hsueh AJ, Dufau ML & Catt KJ (1977) Gonadotropin-induced regulation of luteinizing hormone receptors and desensitization of testicular 3":5"-cyclic AMP and testosterone responses.” Proc Nat Acad Sc U S A 74(2): 592-595.
Hsueh AJ & Erickson GF (1979) Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis. Science 204(4395): 854-855.
Hsueh AJ, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW & Vale W (1987) Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Nat Acad Sc U S A 84(14): 5082-5086.
Hudson RW, Lochnan HA, Danby FW, Margesson LJ, Strang BK & Kimmett SM (1990) 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism. Fertil Steril 54(6): 1065-1071.
Hulka BS, Chambless LE, Kaufman DG, Fowler WC Jr & Greenberg BG (1982) Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA 247(4): 475-477.
Hull MG (1992) Infertility treatment: relative effectiveness of conventional and assisted conception methods. Hum Reprod 7(6): 785-796.
Ibanez L, Hall JE, Potau N, Carrascosa A, Prat N & Taylor AE (1996) Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J Clin Endocrinol Metab 81(11): 4103-4107.
Ibanez L, de Zegher F & Potau N (1998) Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest 21(9): 558-566.
Ibanez L, Potau N, Marcos MV & de Zegher F (1999) Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 84(12): 4739-4741.
Ibanez L, Valls C, Potau N, Marcos MV & de Zegher F (2000) Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 85(10): 3526-3530.
Ihle JN (1996) Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv Canc Res 68: 23-65.
Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V & Shulman GI (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338(13): 867-872.
Ipp E, Dobbs R & Unger RH (1978) Morphine and beta-endorphin influence the secretion of the endocrine pancreas. Nature 276(5684): 190-191.
Isojarvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT & Myllyla VV(1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 329(19):1383-1388.
Isojärvi J & Tapanainen J (2000) Valproate, hyperandrogenism, and polycystic ovaries: A report of 3 cases. Arch Neurol 57(7): 1064-1068.
Jacobs HS & Conway GS (1999) Leptin, polycystic ovaries and polycystic ovary syndrome.” Hum Reprod Update 5(2): 166-171.
Jakubowicz DJ & Nestler JE (1997) 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab 82(2): 556-560.
Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R & Nestler JE (2001) Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 86(3): 1126-1133.
John ME, Simpson ER, Waterman MR & Mason JI (1986) Regulation of cholesterol side-chain cleavage cytochrome P-450 gene expression in adrenal cells in monolayer culture. Mol Cell Endocrinol 45(2-3): 197-204.
Kaaja R, Laivuori H, Laakso M, Tikkanen MJ & Ylikorkala O (1999) Evidence of a state of increased insulin resistance in preeclampsia. Metab: Clin Exp 48(7): 892-896.
Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F & Kosaka K (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26(1): 44-49.
Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C & Taylor SI (1988) Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240(4853): 787-790.
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM & Roth J (1976) The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 294(14): 739-745.
Karlsson C, Lindell K, Svensson E, Bergh C, Lind P, Billig H, Carlsson LM & Carlsson B (1997) Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 82(12): 4144-4148.
Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q & Garvey WT (1997) The Metabolic Significance of Leptin in Humans: Gender-Based Differences in Relationship to Adiposity, Insulin Sensitivity, and Energy Expenditure. J Clin Endocrinol Metab 82(4): 1293-1300.
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ & Franks S (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36(1): 105-111.
Kirschner MA, Zucker IR & Jespersen D (1976) Idiopathic hirsutism--an ovarian abnormality. N Engl J Med 294(12): 637-640.
Kissebah AH & Peiris AN (1989) Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diab-Metab Rev 5(2): 83-109.
Knecht M, Feng P & Catt KJ (1986) Transforming growth factor-beta regulates the expression of luteinizing hormone receptors in ovarian granulosa cells. Biochem Biophys Res Comm 139(2): 800-807.
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83(9): 3078-3082.
Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J & Caro JF (1996) Acute and Chronic Effects of Insulin on Leptin Production in Humans: Studies in vivo and in vitro. Diabetes 45: 699-701.
Korytkowski MT, Mokan M, Horwitz MJ & Berga SL (1995) Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab 80(11): 3327-3334.
Kosaka K, Kuzuya T, Hagura R & Yoshinaga H (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diab Med 13(9 Suppl 6): S109-119.
Kousta E, Cela E, Lawrence N, Penny A, Millauer B, White D, Wilson H, Robinson S, Johnston D, McCarthy M & Franks S (2000) The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol 53(4): 501-507.
Kovacs G, Buckler H, Bangah M, Outch K, Burger H, Healy D, Baker G & Phillips S (1991) Treatment of anovulation due to polycystic ovarian syndrome by laparoscopic ovarian electrocautery. Br J Obstet Gynaecol 98(1): 30-35.
Kuhl C (1977) Serum insulin and plasma glucagon in human pregnancy on the pathogenesis of gestational diabetes. A review. Acta Diabetol Lat 14(1-2): 1-8.
Kurioka H, Takahashi K, Irikoma M, Okada M, Ozaki T, Ueda T & Miyazaki K (1999) Diagnostic difficulty in polycystic ovary syndrome due to an LH-beta-subunit variant. Eur J Endocrinol 140(3): 235-238.
Kuttenn F, Rigaud C, Wright F & Mauvais-Jarvis P (1980) Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. J Clin Endocrinol Metab 51(5): 1107-1111.
la Marca A, Morgante G, Paglia T, Ciotta L, Cianci A & De Leo V (1999) Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. Fertil Steril 72(6): 985-989.
la MarcaA, Egbe TO, Morgante G, Paglia T, Cianci A, De Leo V & Ciani A (2000) Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Human Reprod 15(1): 21-23.
Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T & Penttila I (1988) Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metab: Clin Exp 37(11): 1092-1100.
Lachelin GC, Barnett M, Hopper BR, Brink G & Yen SS (1979) Adrenal function in normal women and women with the polycystic ovary syndrome. J Clin Endocrinol Metab 49(6): 892-898.
Laivuori H, Tikkanen MJ & Ylikorkala O (1996) Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 81(8): 2908-2911.
Laivuori H, Kaaja R, Rutanen EM, Viinikka L & Ylikorkala O (1998) Evidence of high circulating testosterone in women with prior preeclampsia.” J Clin Endocrinol Metab 83(2): 344-347.
Laivuori H, Kaaja R, Koistinen H & Karonen SL (2000) Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metab: Clin Exp 49(2): 259-263.
l"Allemand D, Penhoat A, Lebrethon MC, Ardevol R, Baehr V, Oelkers W & Saez JM (1996) Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab 81(11): 3892-3897.
Lambert-Messerlian G, Taylor A, Leykin L, Isaacson K, Toth T, Chang Y & Schneyer A (1997) Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol Reprod 57: 1211-1216.
Lanzone A, Fulghesu AM, Fortini A, Cutillo G, Cucinelli F, Di Simone N, Caruso A & Mancuso S (1991) Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum Reprod 6(8): 1043-1049.
Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM & Mancuso S (1995a) Polycystic ovary disease. A risk factor for gestational diabetes? J Reprod Med 40(4): 312-316.
Lanzone A, Fulghesu AM, Cucinelli F, Ciampelli M, Caruso A & Mancuso S (1995b). Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion. J Clin Endocrinol Metab 80(12): 3501-3506.
Lanzone A, Fulghesu AM, Cucinelli F, Guido M, Pavone V, Caruso A & Mancuso S (1996) Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome. Hum Reprod 11(11): 2382-2386.
Larsson H, Elmstahl S & Ahren B (1996) Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 45(11): 1580-1584.
Laughlin GA, Morales AJ & Yen SS (1997) Serum Leptin Levels in Women with Polycystic Ovary Syndrome: the Role of Insulin Resistance/Hyperinsulinemia. J Clin Endocrinol Metab 82(6): 1692-1696.
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI & Friedman JM (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379(6566): 632-635.
Lee PD, Conover CA & Powell DR (1993) Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204(1): 4-29.
Leenen R, van der Kooy K, Seidell JC, Deurenberg P & Koppeschaar HP (1994) Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78(6): 1515-1520.
Legro RS (1998a) Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype. Mol Cell Endocrinol 145(1-2): 103-110.
Legro RS, Finegood D & Dunaif A (1998b) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83(8): 2694-2698.
Legro RS, Kunselman AR, Dodson WC & Dunaif A (1999). “Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84(1): 165-169.
Levran D, Shoham Z, Habib D, Greenwald M & Nebel L (1990) Glucose tolerance in pregnant women following treatment for sterility. Int J Fertil 35(3): 157-159.
Levrant SG, Barnes RB, Rosenfield RL (1997) A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod 12(7): 1416-1420.
Li R, Phillips D.M & Mather JP (1995) Activin promotes ovarian follicle development in vitro. Endocrinology 136: 849–856.
Liao WX, Roy AC, Chan C, Arulkumaran S & Ratnam SS (1998) A new molecular variant of luteinizing hormone associated with female infertility. Fertil Steril 69(1): 102-106.
Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS & Gold PW (1997) Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med 3(5): 575-579.
Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH & Bogardus C (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329(27): 1988-1992.
Lin D, Sugawara T, Strauss JF 3rd, Clark BJ, Stocco DM, Saenger P, Rogol A & Miller WL (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267(5205): 1828-1831.
Ljung T, Andersson B, Bengtsson BA, Bjorntorp P & Marin P (1996) Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Res 4(3): 277-282.
Lobo RA, Granger L, Goebelsmann U & Mishell DR Jr (1981) Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab 52(1): 156-158.
Lobo RA, Paul W, March CM, Granger L & Kletzky OA (1982) Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol 60(4): 497-501.
Lobo RA (1995) Polycystic ovary syndrome/hyperandrogenic chronic anovulation. Adv Endocrinol Metab 6: 167-191.
Lobo RA & Carmina E (2000) The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12): 989-993.
Lucky AW, Rosenfield RL, McGuire J, Rudy S & Helke J (1986) Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 62(5): 840-848.
Lunde O, Magnus P, Sandvik L & Hoglo S (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 28(1): 23-30.
Magoffin DA (1989) Evidence that luteinizing hormone-stimulated differentiation of purified ovarian thecal-interstitial cells is mediated by both type I and type II adenosine 3",5"-monophosphate-dependent protein kinases. Endocrinol 125(3): 1464-73.
Mantzoros CS, Dunaif A & Flier JS (1997) Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 82(6): 1687-1691.
Marshall JC & Eagleson CA (1999) Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol Metab Clin N A 28(2): 295-324.
Martikainen H, Huhtaniemi I & Vihko R (1980) Response of peripheral serum sex steroids and some of their precursors to a single injection of hCG in adult men. Clin Endocrinol 13(2): 157-166.
Martikainen H, Salmela P, Nuojua-Huttunen S, Perälä J, Leinonen S & Knip M (1996) Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril 66(4): 564-570.
Martikainen H, Salmela P, Nuojua-Huttunen S, Perälä J, Leinonen S, Knip M & Ruokonen A (1997) Insulin-like growth factors and their binding proteins in the venous effluents of ovary and adrenal gland in severely hyperandrogenic women. Hum Reprod 12(3): 446-448.
Mason HD, Margara R, Winston RM, Seppala M, Koistinen R & Franks S (1993) Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J Clin Endocrinol Metab 76(5): 1275-1279.
Mason HD, Willis DS, Holly JM & Franks S (1994) Insulin preincubation enhances insulin-like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells. J Clin Endocrinol Metab 78(5): 1265-1267.
Matikainen T, Ding YQ, Vergara M, Huhtaniemi I, Couzinet B & Schaison G (1992) Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women. J Clin Endocrinol Metab 75(3): 820-825.
Matthaei S, Hamann A, Klein HH, Benecke H, Kreymann G, Flier JS & Greten H (1991) Association of Metformin"s effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40(7): 850-857.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
McArthur J W, Ingersoll FM & Worcester J (1958) The urinary excretion of interstitial-cell and follicle stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab 18: 1202-1215.
McFaul PB, Traub AI & Thompson W (1990) Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril 53(5): 792-797.
McKenna TJ, Moore A, Magee F & Cunningham S (1983) Amenorrhea with cryptic hyperandrogenemia. J Clin Endocrinol Metab 56(5): 893-896.
McKenna TJ, Fearon U, Clarke D & Cunningham SK (1997) A critical review of the origin and control of adrenal androgens. Baill Clin Obstet Gynaecol 11(2): 229-248.
McNatty KP, Makris A, DeGrazia C, Osathanondh R & Ryan KJ (1979) The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 49(5): 687-699.
Mesiano S, Katz SL, Lee JY & Jaffe RB (1997) Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J Clin Endocrinol Metab 82(5): 1390-1396.
Messinis IE, Milingos S, Zikopoulos K, Kollios G, Seferiadis K & Lolis D (1998) Leptin concentrations in the follicular phase of spontaneous cycles and cycles superovulated with follicle stimulating hormone. Hum Reprod 13(5): 1152-1156.
Michelmore KF, Balen AH, Dunger DB & Vessey MP (1999) Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 51(6): 779-786.
Mikola M, Hiilesmaa V, Halltunen M, Suhonen L & Tiitinen A (2001) Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 16(2): 226-229.
Mitwally MF, Kuscu NK & Yalcinkaya TM (1999) High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome. Hum Reprod 14(11): 2700-2703.
Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V & Muggeo M (1996a) Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81(3): 881-886.
Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo M & Muggeo M (1996b) The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81(3): 952-960.
Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E & Muggeo M (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85(1): 139-146.
Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G & Yen SS (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 81(8): 2854-2864.
Morin-Papunen LC, Koivunen RM, Ruokonen A & Martikainen HK (1998a) Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 69(4): 691-696.
Morin-Papunen LC, Koivunen RM, Tomas C, Ruokonen A & Martikainen HK (1998b) Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 83(7): 2566-2568.
Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A & Tapanainen JS (2000a) Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovaries. Hum Reprod 15(6): 1266-1274.
Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK & Tapanainen JS (2000b) Endocrine and Metabolic Effects of Metformin versus Ethinyl Estradiol- Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab 85(9): 3161-3168.
Murray RD, Davison RM, Russel RC & Conway GS (2000) Clinical presentation of PCOS following development of an insulinoma: Case report. Hum Reprod 15(1): 86-88.
Naether OG, Fischer R, Weise HC, Geiger-Kotzler L, Delfs T & Rudolf K (1993a) Laparoscopic electrocoagulation of the ovarian surface in infertile patients with polycystic ovarian disease. Fertil Steril 60(1): 88-94.
Naether OG & Fischer R (1993b) Adhesion formation after laparoscopic electrocoagulation of the ovarian surface in polycystic ovary patients. Fertil Steril 60(1): 95-98.
Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN & Blackard WG (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68(6): 1027-1032.
Nestler JE (1993) Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? Clin Endocrinol Metab 76(2): 273-274.
Nestler JE & Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335(9): 617-623.
Nestler JE & Jakubowicz DJ (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82(12): 4075-4079.
Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N & Medina F (1998a) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83(6): 2001-2005.
Nestler JE, Jakubowicz DJ, Evans WS & Pasquali R (1998b) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338(26): 1876-1880.
Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD & Allan G (1999) Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 340(17): 1314-1320.
Neumann F, Berswordt-Wallrabe R vo, Elger W, Steinbeck H, Hahn JD & Kramer M (1970) Aspects of androgen-dependent events as studied by antiandrogens. Rec Progr Horm Res 26: 337-410.
Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM & Huhtaniemi IT (1997) Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril 67(6): 998-1004.
Norman RJ, Hague WM, Masters SC & Wang XJ (1995) Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 10(9): 2258-2261.
Norman RJ, Milner CR, Groome NP & Robertson DM (2001) Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum Reprod 16(4): 668-672.
Nosadini R, Avogaro A, Trevisan R, Valerio A, Tessari P, Duner E, Tiengo A, Velussi M, Del Prato S & De Kreutzenberg S (1987) Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Diab Care 10(1): 62-67.
Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P & Tibblin G (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34(10): 1055-1058.
Okuda K, Yamada T, Imoto H, Komatsubara H & Sugimoto O (1994) Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions.” Biochem Biophys Res Comm 200(1): 584-590.
O"Mara BA, Byers T & Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chr Dis 38(5): 435-441.
O"Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL & Polonsky KS (1993) Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76(5): 1241-1247.
Orsini LF, Venturoli S, Lorusso R, Pluchinotta V, Paradisi R & Bovicelli L (1985) Ultrasonic findings in polycystic ovarian disease. Fertil Steril 43(5): 709-714.
Ortmeyer HK, Huang LC, Zhang L, Hansen BC & Larner J (1993) Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys. Endocrinol 132(2): 646-651.
O"Sullivan JB & Mahan CM (1965) Blood sugar levels, glycosuria, and body weight related to development of diabetes mellitus. The Oxford epidemiologic study 17 years later. JAMA 194(6): 587-592.
Ovesen P, Moller J, Ingerslev HJ, Jorgensen JO, Mengel A, Schmitz O, Alberti KG & Moller N (1993) Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J Clin Endocrinol Metab 77(6): 1636-1640.
Pache TD, Wladimiroff JW, Hop WC & Fauser BC (1992) How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183(2): 421-423.
Papaspyrou-Rao S, Schneider SH, Petersen RN & Fried SK (1997) Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 82(5): 1635-1637.
Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, Caruso A & Lanzone A (1998) Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod 13(3): 542-546.
Pasquali R, Casimirri F, Venturoli S, Paradisi R, Mattioli L, Capelli M, Melchionda N & Labo G (1983) Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol 104(1): 110-116.
Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N & Barbara L (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68(1): 173-179.
Pasquali R, Casimirri F, Plate L & Capelli M (1990) Characterization of obese women with reduced sex hormone-binding globulin concentrations. Horm Metab Res 22(5): 303-306.
Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M & Morselli-Labate AM (2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85(8): 2767-2774.
Peiris AN, Aiman EJ, Drucker WD & Kissebah AH (1989) The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J Clin Endocrinol Metab 68(4): 715-720.
Peng X, Maruo T, Samoto T & Mochizuki M (1996) Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries. Endocr J 43(3): 269-278.
Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P & Bolli GB (1994) Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43(7): 920-928.
Pettersson K, Ding YQ & Huhtaniemi I (1992) An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinol Metab 74(1): 164-171.
Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH & Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51(7): 581-586.
Plehwe WE, Maitland JE, Williams PF, Shearman RP & Turtle JR (1985) Familial hyperinsulinemia complicated by extreme insulin resistance during pregnancy: a probable postreceptor defect. J Clin Endocrinol Metab 61(1): 68-77.
Polan ML, Daniele A, Russell JB & DeCherney AH (1986) Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab 63(6): 1284-1291.
Polderman KH, Gooren LJ, Asscheman H, Bakker A & Heine RJ (1994) Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79(1): 265-271.
Polson DW, Adams J, Wadsworth J & Franks S (1988) Polycystic ovaries--a common finding in normal women. Lancet 1(8590): 870-872.
Poretsky L, Smith D, Seibel M, Pazianos A, Moses AC & Flier JS (1984) Specific insulin binding sites in human ovary. J Clin Endocrinol Metab 59(4): 809-811.
Poretsky L, Cataldo NA, Rosenwaks Z & Giudice LC (1999) The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20(4): 535-582.
Prelevic GM, Wurzburger MI, Balint-Peric L & Ginsburg J (1992) Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 37(4-5): 125-131.
Prelevic GM, Ginsburg J, Maletic D, Hardiman P, Okolo S, Balint-Peric L, Thomas M, Orskov H (1995) The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Hum Reprod 10(1): 28-32.
Purrello F, Gullo D, Brunetti A, Buscema M, Italia S, Goldfine ID & Vigneri R (1987) Direct effects of biguanides on glucose utilization in vitro. Metab: Clin Exp 36(8): 774-776.
Rabin D & McNeil LW (1980) Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocrinol Metab 51(4): 873-876.
Raivio T, Huhtaniemi I, Anttila R, Siimes MA, Hagenas L, Nilsson C, Pettersson K & Dunkel L (1996) The role of luteinizing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys. J Clin Endocrinol Metab 81(9): 3278-3282.
Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I & Clayton RN (1995) Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol 43(3): 297-303.
Ramanujam LN, Liao WX, Roy AC, Loganath A, Goh HH & Ng SC (1999) Association of molecular variants of luteinizing hormone with menstrual disorders. Clin Endocrinol 51(2): 243-246.
Ramanujam LN, Liao WX, Roy AC & Ng SC (2000) Association of molecular variants of luteinizing hormone with male infertility. Hum Reprod 15(4): 925-928.
Randle R, Hales CN, Garland PB & Newsholme EA (1963) The glucose fatty acid cycle and its role in insulin sensitivity and the meatbolic disturbances of diabetes mellitus. Lancet 1: 785-789.
Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G & Naftolin F (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57(5): 1320-1329.
Rebuffe-Scrive M, Cullberg G, Lundberg PA, Lindstedt G & Bjorntorp P (1989) Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res 21(7): 391-397.
Rebuffe-Scrive M, Marin P & Bjorntorp P (1991) Effect of testosterone on abdominal adipose tissue in men. Int J Obesity 15(11): 791-795.
Rheaume E, Lachance Y, Zhao HF, Breton N, Dumont M, de Launoit Y, Trudel C, Luu-The V, Simard J & Labrie F (1991) Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol 5(8): 1147-1157.
Riccio A, Del Prato S, Vigili de Kreutzenberg S & Tiengo A (1991) Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. Diabete et Metabolisme 17(1 Pt 2): 180-184.
Rincon J, Holmang A, Wahlstrom EO, Lonnroth P, Bjorntorp P, Zierath JR & Wallberg-Henriksson H (1996) Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45(5): 615-621.
Rittmaster RS and Thompson DL (1990) Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 70(4): 1096-1102.
Rittmaster RS (1995) Clinical review 73: Medical treatment of androgen-dependent hirsutism. J Clin Endocrinol Metab 80(9): 2559-2563.
Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L & Dewailly D (1995) Ultrasound assessement of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized qualification. Fertil Steril 64(2): 307-312.
Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG & Franks S (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 39: 351-355.
Rodin A, Thakkar H, Taylor N & Clayton R (1994) Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. N Engl J Med 330(7): 460-465.
Roozenburg BJ, van Dessel HJ, Evers JL & Bots RS (1997) Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment. Hum Reprod 12(8): 1720-1722.
Rose DW, Saltiel AR, Majumdar M, Decker SJ & Olefsky JM (1994) Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc Nat Acad Sc U S A 91(2): 797-801.
Rosen CJ, Glowacki J & Craig W (1998) Sex steroids, the insulin-like growth factor regulatory system, and aging: implications for the management of older postmenopausal women. Journal of Nutrition, Health & Aging 2(1): 39-44.
Rosenbaum D, Haber RS & Dunaif A (1993) Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 264(2 Pt 1): E197-202.
Rosenfield RL, Barnes RB, Cara JF & Lucky AW (1990) Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril 53(5): 785-791.
Rosenfield RL, Barnes RB & Ehrmann DA (1994) Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79(6): 1686-1692.
Rosenfield RL (1999) Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin N A 28(2): 265-293.
Roy AC, Liao WX, Chen Y, Arulkumaran S & Ratnam SS (1996) Identification of seven novel mutations in LH beta-subunit gene by SSCP. Mol Cell Biochem 165(2): 151-153.
Roy M, Collier B & Roy A (1990) Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psych Res 31(1): 31-37.
Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS & Sturis J (1995) Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44(5): 506-512.
Sagle MA, Hamilton-Fairley D, Kiddy DS & Franks S (1991) A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril 55(1): 56-60.
Sahin Y, Bayram F, Kelestimur F & Muderris I (1998) Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. J Endocrinol Invest 21(6): 348-352.
Saltiel AR (1996a) Diverse signaling pathways in the cellular actions of insulin. Am J Physiol 270(3 Pt 1): E375-85.
Saltiel AR & Olefsky JM (1996b) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45(12): 1661-1669.
Sampson M, Kong C, Patel A, Unwin R & Jacobs HS (1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol 45(5): 623-629.
San Roman GA & Magoffin DA (1993) Insulin-like growth factor-binding proteins in healthy and atretic follicles during natural menstrual cycles. J Clin Endocrinol Metab 76(3): 625-632.
Sara VR & Hall K (1990) Insulin-like growth factors and their binding proteins. Physiol Rev 70(3): 591-614.
Schalin-Jäntti C, Yki-Järvinen H, Koranyi L, Bourey R, Lindström J, Nikula-Ijas P, Franssila-Kallunki A & Groop LC (1994) Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia 37(4): 401-407.
Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A & Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88(4 Pt 1): 554-559.
Schoot DC, Coelingh Bennink HJ, Mannaerts BM, Lamberts SW, Bouchard P & Fauser BC (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab 74(6): 1471-1473.
Schwander JC, Hauri C, Zapf J & Froesch ER (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113(1): 297-305.
Schwartz NS, Clutter WE, Shah SD & Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79(3): 777-781.
Segal KR, Landt M & Klein S (1996) Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45(7): 988-991.
Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB & Unger RH (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Nat Acad Sc U S A 94(9): 4637-4641.
Shuster LT, Go VL, Rizza RA, O"Brien PC & Service FJ (1988) Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes 37(2): 200-203.
Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C & Caro JF (1996) Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97(5): 1344-1347.
Smals AG, Pieters GF, Drayer JI, Benraad TJ & Kloppenborg PW (1979) Leydig cell responsiveness to single and repeated human chorionic gonadotropin administration. J Clin Endocrinol Metab 49(1): 12-14.
Smitz J, Cortvrindt R, Hu Y & Vanderstichele H (1998) Effects of recombinant activin A on in vitro culture of mouse preantral follicles. Mol Reprod Dev 50: 294–304.
Smyth CD, Miro F, Whitelaw PF, Howles CM & Hillier SG (1993) Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 133(4): 1532-1538.
Spritzer PM, Lisboa KO, Mattiello S & Lhullier F (2000) Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol 52(5): 587-594.
Steil GM, Volund A, Kahn SE & Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42(2): 250-256.
Stein IF & Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29: 181-186.
Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM & Kriauciunas A (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377(6549): 530-532.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312.
Stewart PM, Shackleton CH, Beastall GH & Edwards CR (1990) 5 alpha-reductase activity in polycystic ovary syndrome. Lancet 335(8687): 431-433.
Stowers JM, Sutherland HW & Kerridge DF (1985) Long-range implications for the mother. The Aberdeen experience. Diabetes 34(Suppl 2): 106-110.
Stumvoll M, Nurjhan N, Perriello G, Dailey G & Gerich JE (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. New England Journal of Medicine 333(9): 550-4.
Suganuma N, Furui K, Kikkawa F, Tomoda Y & Furuhashi M (1996) Effects of the mutations (Trp8 --> Arg and Ile15 --> Thr) in human luteinizing hormone (LH) beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology 137(3): 831-838.
Suikkari AM, Sane T, Seppälä M, Yki-Järvinen H, Karonen SL & Koivisto VA (1989) Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J Clin Endocrinol Metab 68(1): 141-144.
Suikkari AM, Ruutiainen K, Erkkola R & Seppälä M (1989) Low levels of low molacular weight insulin-like growth factor- binding protein in patients with polycystic ovarian disease. Hum Reprod 4: 136-139.
Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL & McLachlan RI (1995) Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod 10(3): 513-519.
Swanson M, Sauerbrei EE & Cooperberg PL (1981) Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultras 9(5): 219-222.
Takahashi K, Yoshino K, Nishigaki A, Eda Y & Kitao M (1992) On the relationship between endocrine and ovulatory abnormalities, and polycystic ovaries as diagnosed by ultrasonography. Int J Fertil 37(4): 222-226.
Takahashi K, Kurioka H, Ozaki T, Kanasaki H, Kohsaka M, Miyazaki K & Karino K (1998) Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum Reprod 13(12): 3338-3344.
Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA (1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51(5): 415-422.
Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE & Kuller LH (2000) Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20(11): 2414-2421.
Tanbo T, Dale PO, Kjekshus E, Haug E & Abyholm T (1990) Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril 53(5): 798-803.
Tapanainen J, Martikainen H, Dunkel L, Perheentupa J & Vihko R (1983) Steroidogenic response to a single injection of hCG in pre- and early pubertal cryptorchid boys. Clinical Endocrinology 18(4): 355-362.
Tapanainen J, McCamant S, Orava M, Rönnberg L, Martkainen H, Vihko R & Jaffe RB (1991) Regulation of steroid and steroid sulfate production and aromatase activity in cultured human granulosa-luteal cells. J Ster Biochem Mol Biol 39(1): 19-25.
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT & Deeds J (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83(7): 1263-1271.
Tartagni M, Schonauer LM, De Salvia MA, Cicinelli E, De Pergola G & D"Addario V (2000) Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 73(4): 718-723.
Taylor AE (2000a) Insulin-lowering medications in polycystic ovary syndrome. Obstet Gynecol Clin N A 27(3): 583-95.
Taylor AE (2000b) The gonadotropic axis in hyperandrogenic adolescents. J Pediatr Endocrinol Metab 13(Suppl 5): 1281-1284.
Teirmaa T, Luukkaa V, Rouru J, Koulu M & Huupponen R (1998) Correlation between circulating leptin and luteinizing hormone during the menstrual cycle in normal-weight women. Eur J Endocrinol 139(2): 190-194.
Teissier MP, Chable H, Paulhac S & Aubard Y (1999) Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology. Hum Reprod 14(9): 2236-2241.
Themmen APN & Huhtaniemi IT (2000) Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21(5): 551-83.
Tiitinen AE, Laatikainen TJ & Seppala MT (1993) Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease. Fertil Steril 60(1): 58-62.
Tiitinen A, Simberg N, Stenman UH & Ylikorkala O (1994) Estrogen replacement does not potentiate gonadotrophin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism. J Clin Endocrinol Metab 79(2): 447-451.
Tsuruhara T, Dufau ML, Cigorraga S & Catt KJ (1977) Hormonal regulation of testicular luteinizing hormone receptors. Effects on cyclic AMP and testosterone responses in isolated Leydig cells. J Biol Chem 252(24): 9002-9009.
Tuckerman EM, Okon MA, Li T & Laird SM (2000) Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74(4): 771-779.
Tulppala M, Huhtaniemi I & Ylikorkala O (1998) Genetic variant of luteinizing hormone in women with a history of recurrent miscarriage. Hum Reprod 13(1O): 2699-2702.
Unluhizarci K, Kelestimur F, Sahin Y & Bayram F (1999a) The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome. Eur J Endocrinol 140(1): 56-61.
Unluhizarci K, Kelestimur F, Bayram F, Sahin Y & Tutus A (1999b) The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol 51(2): 231-236.
Urman B, Sarac E, Dogan L & Gurgan T (1997) Pregnancy in infertile PCOD patients. Complications and outcome. Journal of Reproductive Medicine 42(8): 501-505.
Waldstreicher J, Santoro NF, Hall JE, Filicori M & Crowley WF (1988) Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 66(1): 165-172.
Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F & Arner P (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47(6): 913-917.
Wang CF & Gemzell G (1980) The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 33(5): 479-486.
Vara P & Niemineva K (1951) Small cystic degeneration of ovaries as incidental finding in gynegological laparotomies. Acta Obstet Gynecol Scand 31: 94-99.
Wareham NJ, Phillips DI, Byrne CD & Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diab Med 12(10): 931.
Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S & Williamson R (1997) Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349(9057): 986-990.
Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M & Laakso M (1998a) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101(1): 86-96.
Vauhkonen I, Niskanen L, Haffner S, Kainulainen S, Uusitupa M & Laakso M (1998b) Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus. Eur J Endocrinol 139(6): 598-604.
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF & Jameson JL (1992) Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Medi 326(3): 179-183.
Velazquez EM, Mendoza S, Hamer T, Sosa F & Glueck CJ (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metab: Clin Exp 43(5): 647-654.
Velazquez E, Acosta A & Mendoza SG (1997) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90(3): 392-395.
White MF (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182(1-2): 3-11.
Widen EI, Eriksson JG & Groop LC (1992) Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 41(3): 354-358.
Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A & Giacca A (1999) Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48(4): 766-774.
Wild RA, Umstot ES, Andersen RN & Givens JR (1982) Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab 54(4): 676-681.
Wild RA, Painter PC, Coulson PB, Carruth KB & Ranney GB (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 61(5): 946-951.
Wild RA, Bartholomew M, Applebaum-Bowden D, Demers LM, Hazzard W & Santen RJ (1990) Evidence of heterogeneous mechanisms in lipoprotein lipid alterations in hyperandrogenic women. Am J Obstet Gynecol 163(6 Pt 1): 1998-2005.
Wild S, Pierpoint T, McKeigue P & Jacobs H (2000) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 52(5): 595-600.
Willis D & Franks S (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80(12): 3788-3790.
Willis D, Mason H, Gilling-Smith C & Franks S (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81(1): 302-309.
Willis DS, Watson H, Mason HD, Galea R, Brincat M & Franks S (1998) Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 83(11): 3984-3991.
Winters SJ, Talbott E, Guzick DS, Zborowski J & McHugh KP (2000) Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 73(4): 724-729.
Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S & White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391(6670): 900-904.
Vollenhoven B, Clark S, Kovacs G, Burger H & Healy D (2000) Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynaecol 40(1): 54-58.
Wortsman J, de Angeles S, Futterweit W, Singh KB & Kaufmann RC (1991) Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 36(9): 659-661.
Wu MH, Tang HH, Hsu CC, Wang ST & Huang KE (1998) The role of three-dimensional ultrasonographic images in ovarian measurement. Fertil Steril 69(6): 1152-1155.
Wu MS, Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, Chen YD & Reaven GM (1990) Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diab Care 13(1): 1-8.
Wu X, Sallinen K, Anttila L, Mäkinen M, Luo C, Pöllanen P & Erkkola R (2000) Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls. Fertil Steril 74(3): 564-572.
Yada H, Hosokawa K, Tajima K, Hasegawa Y & Kotsuji F (1999) Role of ovarian theca and granulosa cell interaction in hormone productionand cell growth during the bovine follicular maturation process. Biol Reprod 61(6): 1480-1486.
Yeh HC, Futterweit W & Thornton JC (1987) Polycystic ovarian disease: US features in 104 patients. Radiology 163(1): 111-116.
Yen SS, Vela P & Rankin J (1970) Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30(4): 435-442.
Yen SSC (1999) Polycystic ovary syndrome (Hyperandrogenic chronic anovulation). Philadelphia, W.B. Saunders Company.
Zawadzki J & Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Boston, Blackwell.
Zhang LH, Rodriguez H, Ohno S & Miller WL (1995) Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Nat Acad Sc U S A 92(23): 10619-10623.